Using EGFR Antibodies as a First Line Therapy Depending on Tumor Sidedness - 101341

Spotlight
Video

Using EGFR Antibodies as a First Line Therapy Depending on Tumor Sidedness

obr has 439 videos Subscribe Here

Loading........
Description: The choice of first line therapy differs on tumor sidedness. Professor Alan P. Venook, MD, joins us from the 2018 Gastrointestinal Cancers Symposium and talks about the deciding factor when it comes to the first line of therapy for either left-sided or right-sided patients.
Shared By : obr
Posted on : 01/29/18
Added : 7 months ago